Capital Stock | 7. Capital Stock Share Capital The Company’s Restated Articles of Incorporation authorize the Company to issue an unlimited number of common shares. Schedule of Share Capital Activity Number of units $ (000 ’s) Balance at September 1, 2019 150,391,558 $ 108,218 Issued for cash, net of share issue costs 6,768,634 3,441 Shares issued for settlement of convertible and gold loans 29,267,417 11,382 Transfer of conversion component on conversion of convertible loans - 4,286 Shares issued for interest on gold and convertible loans 1,463,855 584 Shares issued for services 5,623,000 3,228 Finders fees on convertible and gold bullion loans 1,025,762 477 Warrants exercised 5,434,896 3,484 Balance at August 31, 2020 199,975,122 $ 135,100 Issued for cash, net of share issue costs 38,477,666 23,226 Warrants issued - (8,710 ) Issued for settlement of convertible debentures (Note 25) 12,150,447 7,015 Issued for settlement of debts related to convertible and gold loans (Note 25) 4,266,321 1,497 Options exercised 1,000 - Transfer of reserve on exercise of options - 1 Balance at August 31, 2021 254,870,556 $ 158,129 Activity during the year ended August 31, 2021: On February 11, 2021, the Company completed the sale of 32,923,078 16,461,539 21.4 The common shares and warrants were issued at $0.65 for each common share and a purchase warrant with the right of each whole warrant to purchase one common share at $0.80 for a period of five years from the issue date. The Company also issued 1,152,307 broker warrants with the same terms and incurred commission and other costs of $1.8 million out of which $0.7 million was allocated to the warrants issued in the unit and expensed in the statement of comprehensive loss. On December 23, 2020, the Company completed the sale of 5,554,588 2,777,268 3.0 0.54 1.50 During the year ended August 31, 2021 $ 7.0 12,150,447 7.0 Activity during the year ended August 31, 2020: During the year ended August 31, 2020, the Company issued 6,768,634 0.575 0.5 3.4 During the year ended August 31, 2020, 4,017,857 September 26, 2021 5,434,896 3.5 During the year ended August 31, 2020, 1,463,855 at an average price of $0.41 per share for total issued value of $ 0.6 On April 15, 2020 the Company issued 5,623,000 0.57 3.2 Warrant issuances: Activity during the year ended August 31, 2021: During the year ended August 31, 2021, the Company issued 2,777,268 three-year warrants with an exercise price of $ 1.50 16,461,539 five-year warrants with an exercise price of $ 0.80 The 2,777,268 three-year warrants were ascribed a fair value of $ 0.4 0 0.18 69 36 The 16,461,539 five-year warrants were ascribed a fair value of $ 7.8 0 0.46 62 60 The 1,152,307 0.5 0 0.46 62 60 Activity during the year ended August 31, 2020: During the year ended August 31, 2020, the Company issued three-year warrants with an exercise price of $ 1.2125 Warrants and Compensation Options outstanding: The continuity of outstanding warrants for the years ended August 31, 2021 and 2020 is as follows: Schedule of warrants outstanding Number of stock options Weighted average exercise price per share Balance – August 31, 2019 4,305,758 1.09 Warrants exercised (4,017,857 ) 1.10 Warrants issued 3,002,037 1.21 Balance – August 31, 2020 3,289,938 1.19 Warrants issued 20,391,114 0.89 Balance – August 31, 2021 23,681,052 0.94 At August 31, 2021, the following warrants and compensation warrants were outstanding: Schedule of warrants and compensation warrants Number of Exercise price Expiry date Private placement financing agent warrants - September 1, 2016 73,616 $ 0.8718 September 1, 2021 Private placement financing agent warrants - September 26, 2016 214,285 $ 0.9515 September 26, 2021 Convertible debenture warrants - July 27, 2020 3,002,037 $ 1.2125 July 27, 2023 Private placement financing warrants - December 23, 2020 2,777,268 $ 1.50 December 23, 2023 Private placement financing warrants - February 11, 2021 16,461,539 $ 0.80 February 11, 2026 Private placement financing broker warrants - February 11, 2021 1,152,307 $ 0.80 February 11, 2026 Balance, August 31, 2021 23,681,052 - - The outstanding warrants have a weighted average exercise price of $ 0.94 3.8 Omnibus Equity Incentive Plan Effective June 26, 2019, the Company adopted the Omnibus Equity Incentive Plan dated June 26, 2019 (the “Omnibus Plan”), which Omnibus Plan was approved by the shareholders at a meeting held on August 16, 2019. The purposes of the Omnibus Plan are: (a) to advance the interests of the Company by enhancing the ability of the Company and its subsidiaries to attract, motivate and retain employees, officers, directors, and consultants, which either of directors or officers may be consultants or employees; (b) to reward such persons for their sustained contributions; and (c) to encourage such persons to take into account the long-term corporate performance of the Company. The Omnibus Plan provides for the grant of options, restricted share units, deferred share units and performance share units (collectively, the “Omnibus Plan Awards”), all of which are described in detail in the Form 20-F Annual Report for the year ended August 31, 2021. The Omnibus Plan provides for the grant of other share-based awards to participants (“Other Share-Based Awards”), which awards would include the grant of common shares. All Other Share-Based Awards will be granted by an agreement evidencing the Other Share-Based Awards granted under the Omnibus Plan. Subject to adjustments as provided for under the Omnibus Plan, the maximum number of shares issuable pursuant to Omnibus Plan Awards outstanding at any time under the Omnibus Plan shall not exceed 10% of the aggregate number of common shares outstanding from time to time on a non-diluted basis; provided that the acquisition of common shares by the Company for cancellation shall not constitute non-compliance with the Omnibus Plan for any Omnibus Plan Awards outstanding prior to such purchase of common shares for cancellation. As at August 31, 2021, the Company had 12,513,055 7,022,512 The continuity of outstanding stock options for the years ended August 31, 2021 and 2020 is as follows: Schedule of continuity of outstanding stock options Number of stock options Weighted average exercise price per share Balance – August 31, 2019 and 2020 7,352,000 CAD $ 0.41 Options exercised (1,000 ) CAD $ 0.40 Balance – August 31, 2021 7,351,000 CAD $ 0.41 Options to purchase common shares carry exercise prices and terms to maturity as follows: Schedule of Options to purchase common shares carry exercise prices and terms to maturity Remaining Exercise price (1) Number of options Expiry contractual Outstanding $ Outstanding Exercisable Date life (years) (1) CAD $ 0.40 3,719,000 3,719,000 September 29, 2026 5.1 CAD $ 0.43 3,532,000 3,532,000 October 11, 2026 5.1 CAD $ 0.35 100,000 100,000 January 2, 2028 6.3 CAD $ 0.41 7,351,000 7,351,000 5.1 (1) Total represents weighted average. |